P-134 Symptoms matter; an audit of symptomatic management of malignant bowel obstruction

Octreotide for Malignant Bowel Obstruction (DRAFT)

10.1093/med/9780190658618.003.0026 ◽

2018 ◽

Author(s):

Shalini Dalal

Keyword(s):

Prospective Study ◽

Bowel Obstruction ◽

Clinical Case ◽

Malignant Bowel Obstruction ◽

Advanced Cancer Patients ◽

Symptomatic Management ◽

A Prospective Study ◽

Study Intervention

This chapter describes a prospective study published in 2002 evaluating the role of octreotide in the symptomatic management of advanced cancer patients with bowel obstruction that cannot be treated surgically. The chapter describes the basics of the study, including funding, year study began, year study was published, study location, who was studied, who was excluded, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. The chapter briefly reviews other relevant studies and information, gives a summary and discusses implications, and concludes with a relevant clinical case. Topics covered include octreotide, bowel obstruction, vomiting, and abdominal distention.

Download Full-text

A REGIONAL RE-AUDIT OF THE SYMPTOMATIC MANAGEMENT OF NAUSEA & VOMITING IN THE MEDICAL MANAGEMENT OF MALIGNANT BOWEL OBSTRUCTION

BMJ Supportive & Palliative Care ◽

10.1136/bmjspcare-2014-000654.194 ◽

2014 ◽

Vol 4 (Suppl 1) ◽

pp. A68.2-A68

Author(s):

Timothy Jackson ◽

David Waterman ◽

Ashique Ahamed ◽

Rebecca Lennon ◽

Julie Suman ◽

...

Keyword(s):

Bowel Obstruction ◽

Medical Management ◽

Malignant Bowel Obstruction ◽

Symptomatic Management

Download Full-text

Regional audit on the symptomatic management of nausea & vomiting in the medical management of malignant bowel obstruction

BMJ Supportive & Palliative Care ◽

10.1136/bmjspcare-2012-000196.193 ◽

2012 ◽

Vol 2 (Suppl 1) ◽

pp. A66.2-A66

Author(s):

Elizabeth O'Brien ◽

Laura Edwards ◽

Aaron Sutherland ◽

Kath Mitchell ◽

Maxine Concannon ◽

...

Keyword(s):

Bowel Obstruction ◽

Medical Management ◽

Malignant Bowel Obstruction ◽

Symptomatic Management

Download Full-text

Percutaneous venting gastrostomy/gastrojejunostomy for malignant bowel obstruction: a qualitative study

BMJ Supportive & Palliative Care ◽

10.1136/bmjspcare-2019-001866 ◽

2019 ◽

pp. bmjspcare-2019-001866

Author(s):

Rebecca Singh Curry ◽

Elizabeth Evans ◽

Anne-Marie Raftery ◽

Julia Hiscock ◽

Marlise Poolman

Keyword(s):

Bowel Obstruction ◽

Medical Information ◽

Information Provision ◽

Malignant Bowel Obstruction ◽

Advanced Malignancy ◽

Patient Demographics ◽

Patient Interviews ◽

Referral Criteria ◽

Symptomatic Management ◽

The Impact

ObjectiveMalignant bowel obstruction (MBO) is a complication of advanced malignancy and is associated with a short prognosis. MBO can infrequently be reversed by surgery or stenting. The focus of treatment is usually symptomatic management, of which percutaneous venting gastrostomy/gastrojejunostomy (PVG) is one consideration. There is little data considering the impact of PVG on quality of life; we therefore aimed to explore this.MethodsWe identified patients with a PVG inserted for MBO and those who consented to participate were interviewed. The interviews were audio recorded, transcribed and analysed using Framework. Alongside patient interviews, a data collection tool was designed and used to record patient demographics and medical information, enabling us to contextualise individual patients’ experiences.Results11 patients were interviewed and 10 patients’ data were analysed (1 patient withdrew). No patients regretted having a PVG and many benefitted symptomatically and psychosocially. Challenges encountered included practical issues, pain and PVG tube complications.ConclusionsThe analysis provided a detailed insight into the impact of PVG insertion and demonstrated that each patient’s experience is shaped by a complex interplay of individual factors, thereby highlighting the need to improve referral criteria and individualise patient selection. Other service improvements include enhancing information provision for patients and training for healthcare professionals, thus aiming to mitigate the challenges experienced. Our study is the first in-depth exploration of patients’ experiences of PVG at a tertiary cancer centre. Ensuring that the insights from this study are fed back to guide future service provision is critical in enhancing future patient experiences.

Download Full-text